Omeros stock tumbles after EMA panel rejects narsoplimab application

Cevap yazmak için giriş yap yada kayıt ol.
Benzer konular Forum Tarih
A Genworth Financial stock hits 52-week high at $9.45 Hisse Senetleri 0 1
A UBS reiterates Buy on Teva Pharma stock, keeps $42 price target Hisse Senetleri 0 1
A UBS reiterates Liberty Energy stock rating on strong utilization Hisse Senetleri 0 1
A UBS reiterates Buy on Five Below stock, keeps $285 price target Hisse Senetleri 0 1
A Omeros stock tumbles after EU panel rejects Yartemlea Hisse Senetleri 0 1
A how Fair Value analysis identified Omeros’ 74% biotech breakout Hisse Senetleri 0 34
A Omeros stock rises as first commercial YARTEMLEA shipments begin Hisse Senetleri 0 20
A Omeros VP Borges sells $750k in shares Hisse Senetleri 0 30

Benzer konular

Üst